Pharma: Stay bullish, but hedge to avoid mistake of selling due to deadline. 7 stocks with upside potential of up to 50%

While Democrats are better known to push for lower drug prices in the US, in recent times even Republicans are talking about keeping the cost of healthcare low. Logically, if the US wants to keep costs low, there cannot be any tariff wars in the pharma sector. But logic does not work in President Trump’s New World Order, where offers can be made to buy countries! But even in a New World Order, investors should not sell stocks from a sector which is doing well and is likely to do well in future because it fulfills a need which is very basic. One just needs to manage an event risk which might take place on April 2 as the reciprocal tariffs kick in. And that is not rocket science.